Invitation to the presentation of Recipharm’s interim report for the third quarter 2020
Recipharm AB will publish its interim report for the third quarter 2020 on 5th November at 07:45 am CET.
The company invites investors, analysts and media to a web conference (in English) on 5th November at 10:00 am CET, where CEO Thomas Eldered and CFO Tobias Hägglöv will present and comment on the report as well as answer questions. The presentation can be followed live, or afterwards on www.recipharm.com/investor-relations.
The report will be available on www.recipharm.com/investor-relations from 7:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 5th November.
Click here to participate in the web conference.
Questions may be submitted by dialling below telephone numbers during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.
From Sweden: +46 8 566 426 51
From France: + 33 170 750 711
From Germany: +49 691 380 34 30
From India: +91 227 127 96 10
From Israel: +972 372 076 79
From Italy: +39 023 601 38 21
From Portugal: +351 210 609 105
From Spain: +34 935 472 900
From the UK: +44 333 300 08 04
From the USA: +1 631 913 14 22
Pin code for participants:
67679708#
After the live event the webcast will be available on-demand via the same link.
For more information, please contact:
ir@recipharm.com, telephone: +46 8 602 52 00
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com
Tags: